Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Entheon Biomedical ( (TSE:ENBI) ) just unveiled an update.
Entheon Biomedical Corp. has successfully closed a non-brokered private placement financing, raising CDN$500,000 through the issuance of 5,000,000 units at CDN$0.10 each. The funds will be used for general working capital, and the securities are subject to a hold period until May 4, 2025. This move supports Entheon’s operational funding needs and potentially strengthens its market positioning in the biotechnology sector focused on addiction treatment.
More about Entheon Biomedical
Entheon Biomedical is a biotechnology research and development company focused on treating addiction and substance use disorders.
YTD Price Performance: -11.68%
Average Trading Volume: 2,897
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $1.11M
See more insights into ENBI stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue